Radius, 3M Drug Delivery partner on osteoporosis drug; OptiNose wins award for nasal delivery;

> Radius Health and 3M Drug Delivery Systems are getting together to develop a transdermal version of BA058, which is Radius' parathyroid hormone-related protein analog to treat osteoporosis. Story

> OptiNose has won an innovation award in Oslo for its nasal drug delivery technology. It should be given an award for a great company name, too--second only to Cyrano Sciences and its Cyranose electronic odor detector. OptiNose release

> Serina Therapeutics has developed a new way of synthesizing polyoxazoline polymers for drug delivery applications that it says is free of the drawbacks that have hampered previous production methods. Story

> UK-based drug-delivery company Q Chip has completed a $6 million funding round, which it plans to spend on developing its bio-encapsulation and drug delivery platform for long-acting injectable therapeutics with tailored sustained-release profiles and improved administration, according to a news release. Q Chip release

> Novozymes Biopharma will launch a new grade of its Bacillus-derived hyaluronic acid for ophthalmic delivery applications later this year. Story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.